#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	656	2982	16S	1529	1077	99.91	16S.l15.c30.ctg.1	1487	398.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	998	998	T	427	T,C,A,G	191,175,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	656	2982	16S	1529	1077	99.91	16S.l15.c30.ctg.1	1487	398.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	732	732	C	430	C,T,A	357,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5108	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3946	386.6	0	.	n	.	0	T695C	SNP	695	695	T	1234	1234	C	405	C,A	337,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5108	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3946	386.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2510	2510	C	480	C,T	401,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5108	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3946	386.6	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3136	3136	T	395	T,C	324,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5108	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3946	386.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2584	2584	A	506	A	424	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	540	folP	855	855	100.0	folP.l15.c4.ctg.1	1928	83.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1316	1318	AGC	132;132;131	A,C;G,T;C	102,1;109,1;109	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1176	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3857	91.4	1	SNP	p	S91F	1	.	.	271	273	TTC	812	814	TTC	117;117;116	T;T;C	98;102;103	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1176	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3857	91.4	1	SNP	p	D95G	1	.	.	283	285	GGC	824	826	GGC	115;115;114	G;G;C	101;100;98	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1176	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3857	91.4	1	SNP	p	G95N	0	.	.	283	285	GGC	824	826	GGC	115;115;114	G;G;C	101;100;98	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	498	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1753	84.9	1	SNP	p	G45D	0	.	.	133	135	GGC	648	650	GGC	127;128;128	G;G;C	109;109;109	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	286	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1511	56.7	0	.	n	.	0	A197.	DEL	197	197	A	832	832	A	114	A	106	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1322	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3260	121.0	1	SNP	p	D86N	0	.	.	256	258	GAC	689	691	GAC	139;137;138	G;A;C	111;107;109	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1322	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3260	121.0	1	SNP	p	R87I	0	.	.	259	261	CGT	692	694	CGT	139;139;139	C;G,A;T	112;110,1;109	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1322	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3260	121.0	1	SNP	p	S87R	1	.	.	259	261	CGT	692	694	CGT	139;139;139	C;G,A;T	112;110,1;109	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1322	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3260	121.0	1	SNP	p	R87W	0	.	.	259	261	CGT	692	694	CGT	139;139;139	C;G,A;T	112;110,1;109	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1322	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3260	121.0	1	SNP	p	S88P	0	.	.	262	264	TCC	695	697	TCC	140;141;141	T;C;C	105;112;111	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	878	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3120	84.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1859	1861	GGC	111;111;111	G;G,C;C,A	94;93,1;91,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	862	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2866	89.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1500	1502	GCC	124;123;123	G;C;C	104;106;109	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	862	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2866	89.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1503	1505	ATG	123;123;124	A;T;G	106;105;102	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	862	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2866	89.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1515	1517	ACC	129;128;128	A;C;C,A	105;102;106,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	862	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2866	89.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1515	1517	ACC	129;128;128	A;C;C,A	105;102;106,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	862	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2866	89.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2016	2018	ACC	119;119;120	A;C,A;C	102;96,1;102	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	862	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2866	89.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2070	2072	GCG	117;116;116	G;C;G	100;98;100	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	862	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2866	89.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2070	2072	GCG	117;116;116	G;C;G	100;98;100	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	862	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2866	89.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2193	2195	GGT	118;119;119	G;G;T	103;99;103	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	862	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2866	89.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2202	2204	AGC	120;120;121	A;G;C,A	103;104;106,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	862	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2866	89.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2220	2222	CCG	121;120;120	C;C;G	95;99;96	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1174	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3495	100.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1753	1755	CCG	116;116;116	C;C;G	91;90;91	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	664	porA	1146	1146	99.91	porA.l6.c17.ctg.1	2222	89.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	794	794	C	111	C	94	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	96	porB1a	984	297	91.03	porB1a.l15.c17.ctg.1	1274	20.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1000	1002	AAT	12;12;12	A;A;T	11;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	96	porB1a	984	297	91.03	porB1a.l15.c17.ctg.1	1274	20.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1003	1005	AAT	12;12;12	A;A;T	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	96	porB1a	984	297	91.03	porB1a.l15.c17.ctg.1	1274	20.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1027	1029	GCA	12;12;12	G;C;A	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	96	porB1a	984	297	91.03	porB1a.l15.c17.ctg.1	1274	20.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1050	1052	GTA	10;10;10	G;T;A	9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	96	porB1a	984	297	91.03	porB1a.l15.c17.ctg.1	1274	20.8	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1059	1059	A	10	A	8	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	652	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1559	119.7	0	.	p	.	0	G48E	NONSYN	142	144	GGA	421	423	GAA	138;137;137	G;A;A	111;117;116	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	652	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1559	119.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	907	909	AGA	156;156;158	A,C;G,T;A	128,1;127,1;130	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	652	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1559	119.7	0	.	p	.	0	S217G	NONSYN	649	651	AGT	928	930	GGT	156;155;155	G,A;G;T	127,1;129;127	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	652	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1559	119.7	1	SNP	p	G120K	1	.	.	358	360	AAG	637	639	AAG	154;155;155	A,C;A,C;G,C	126,1;125,1;121,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	652	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1559	119.7	1	SNP	p	N121D	0	.	.	361	363	AAC	640	642	AAC	156;157;158	A,G;A;C	125,1;130;131	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	652	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1559	119.7	1	SNP	p	A121N	1	.	.	361	363	AAC	640	642	AAC	156;157;158	A,G;A;C	125,1;130;131	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2142	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5164	124.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	322	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1243	76.7	1	SNP	p	V57M	1	.	.	169	171	ATG	627	629	ATG	124;124;124	A;T;G	108;109;109	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
